about
Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney diseaseNon-invasive quantification of collagen turnover in renal transplant recipientsAssociation of versican turnover with all-cause mortality in patients on haemodialysis.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in Alkaptonuria.Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease.Clinical evaluation of a matrix metalloproteinase-12 cleaved fragment of titin as a cardiovascular serological biomarker.Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on 'black bone disease' in Italy.Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFThe extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?Urinary collagen degradation products as early markers of progressive renal fibrosisMolecular serum markers of liver fibrosis.The role of extracellular matrix quality in pulmonary fibrosis.The importance of extracellular matrix for cell function and in vivo likeness.Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.High resolution molecular and histological analysis of renal disease progression in ZSF1 fa/faCP rats, a model of type 2 diabetic nephropathy.Precision-Cut Kidney Slices as a Tool to Understand the Dynamics of Extracellular Matrix Remodeling in Renal Fibrosis.Urinary endotrophin predicts disease progression in patients with chronic kidney disease.Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes.Accelerated collagen turnover in women with angina pectoris without obstructive coronary artery disease: An iPOWER substudy.Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.Collagen and tissue turnover as a function of age: Implications for fibrosis.Tumstatin, a Matrikine Derived from Collagen Type IVα3, is Elevated in Serum from Patients with Non-Small Cell Lung Cancer.An exoproteome approach to monitor safety of a cheese-isolated Lactococcus lactisAssessment of extracellular matrix-related biomarkers in patients with lower extremity artery diseaseSuitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisicHigher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and MicroalbuminuriaTurnover of type III collagen reflects disease severity and is associated with progression and microinflammation in patients with IgA nephropathySerum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseasesAtrial fibrillation and cardiac fibrosis: A review on the potential of extracellular matrix proteins as biomarkers
P50
Q33558001-FF56CBF9-9035-457A-B772-CDE67991059CQ33590296-03039305-7156-4462-8D62-43030C1E10A0Q34420828-2C16D455-6228-4085-9D89-139E9ADEC810Q35622533-7254F5AF-8563-437B-9BB1-E22AC1EF984EQ36090540-92BC80BC-F626-48FE-9992-7C47104AA8C5Q36246370-C68DD13E-6C22-4206-AD86-D1BCC05BF8F6Q36367463-DCA49BFE-6975-42E8-A4F9-9062C505E250Q36672445-3CA245FA-F585-45DB-B255-D698A75E3059Q36695799-4A15B558-A184-4245-AE08-C6311539B1ADQ36835374-750DD19B-0B69-448E-856B-74A6DF6F18E6Q37156395-56806F56-F5C4-4B95-842D-BC640182A012Q37702664-5182ED3E-BFBC-44F9-864E-A347AB9A6DD7Q37711116-2EE768AD-2667-4A6F-A609-C25BB7861B94Q38032835-AD92D409-96B0-4CDB-AC65-630E64BF3F2CQ38264047-0AACF328-4E4F-48A2-9739-B31E87CC1CE3Q38321523-CE57A0E1-FE4A-40E1-B720-BDCC138BEE48Q38675211-48129555-4897-4016-94BD-ADC6CA923377Q41137803-652A4C53-0190-4525-9356-D1DD689D80A6Q41834482-B62A5D53-EF04-4614-B4D8-49D3868C5375Q47111536-4D22F8E0-4408-4761-A19D-5C17FB323691Q47677252-1508F8D3-F0E3-49B8-A04A-E75427A0450DQ50049065-2C113B1A-E39F-4B6F-A515-8A996656282BQ51279076-0FDE23ED-8AD5-48A8-ADC0-2EAABBA0734DQ52921939-0B75D213-B31B-448B-A627-D055AE1FB96AQ55307827-53C308B6-56F8-4DAE-864E-1BDEA439FC92Q59462197-090292E0-42C3-4A43-AE41-A3C52BB10941Q59758016-C09C7F5A-5F20-455B-BE74-588D1425EB74Q60631397-A6933586-0C90-4DF4-8CD4-CC8A51679CEFQ61948345-6AC0D934-D164-4B2F-8364-8CCAFECE6D20Q62805910-052238EB-ED89-4628-BC61-4C9B85D94E35Q62805931-20DD8E43-66FF-4C48-A228-4E31BB996AEBQ90602439-C67572F4-807F-4D67-8DE2-F559E681EB12
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Federica Genovese
@ast
Federica Genovese
@en
Federica Genovese
@es
Federica Genovese
@nl
Federica Genovese
@sl
type
label
Federica Genovese
@ast
Federica Genovese
@en
Federica Genovese
@es
Federica Genovese
@nl
Federica Genovese
@sl
prefLabel
Federica Genovese
@ast
Federica Genovese
@en
Federica Genovese
@es
Federica Genovese
@nl
Federica Genovese
@sl
P106
P21
P31
P496
0000-0003-1984-1881